首页|期刊导航|癌症（英文版）|Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

Dong Wang Ruikai Du Suling Liu

癌症（英文版）2017，Vol.36Issue(6)：245-246,2.

癌症（英文版）2017，Vol.36Issue(6)：245-246,2.DOI:10.1186/s40880-017-0204-9

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

Dong Wang ¹Ruikai Du ¹Suling Liu²

作者信息

1. The CAS Key Laboratory of Innate Immunity and Chronic Disease, Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Science and Medical Center, University of Science & Technology of China, Hefei 230027, Anhui, P. R. China
2. Key Laboratory of Breast Cancer in Shanghai, Cancer Institute, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, P. R. China
折叠

摘要

引用本文复制引用

Dong Wang,Ruikai Du,Suling Liu..Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer[J].癌症（英文版）,2017,36(6):245-246,2.

基金项目

This work was supported by National Natural Science Foundation of Chinagrants (Nos. 81530075 and 81472741), the National Key Research andDevelopment Program of China (Stem Cell and Translational Research2016YFA0101202), and the Ministry of Science and Technology (MOST) grant(No. 2015CB553800). （Nos. 81530075 and 81472741）

癌症（英文版）

OACSCDCSTPCDSCI

ISSN：1000-467X

访问量0

下载量0

段落导航